HVC

Healthcare Value Capital Portfolio holdings

AUM $38.5M
This Quarter Return
-0.49%
1 Year Return
+22.29%
3 Year Return
+31.09%
5 Year Return
+125.72%
10 Year Return
–
AUM
$69.3M
AUM Growth
+$69.3M
Cap. Flow
+$6.62M
Cap. Flow %
9.56%
Top 10 Hldgs %
89.99%
Holding
35
New
5
Increased
5
Reduced
5
Closed
7

Top Buys

1
TWM icon
ProShares UltraShort Russell2000
TWM
$9.84M
2
AGN
Allergan plc
AGN
$7.24M
3
ANIP icon
ANI Pharmaceuticals
ANIP
$4.27M
4
LGND icon
Ligand Pharmaceuticals
LGND
$2.35M
5
CLVS
Clovis Oncology, Inc.
CLVS
$1.13M

Top Sells

1
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
$4.6M
2
MRK icon
Merck
MRK
$4.45M
3
SNY icon
Sanofi
SNY
$3.07M
4
AZN icon
AstraZeneca
AZN
$1.79M
5
TEVA icon
Teva Pharmaceuticals
TEVA
$1.61M

Sector Composition

1 Healthcare 77.81%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TWM icon
1
ProShares UltraShort Russell2000
TWM
$34.5M
$11.1M 10.69% 225,000 +200,000 +800% +$9.84M
AMRI
2
DELISTED
Albany Molecular Research Inc
AMRI
$11M 10.61% 498,200 – –
ANIP icon
3
ANI Pharmaceuticals
ANIP
$2.03B
$9.9M 9.55% 350,000 +151,000 +76% +$4.27M
AGN
4
DELISTED
Allergan plc
AGN
$7.24M 6.98% +30,000 New +$7.24M
TEVA icon
5
Teva Pharmaceuticals
TEVA
$21.1B
$5.38M 5.19% 100,000 -30,000 -23% -$1.61M
AZN icon
6
AstraZeneca
AZN
$248B
$5.36M 5.17% 75,000 -25,000 -25% -$1.79M
DGX icon
7
Quest Diagnostics
DGX
$20.3B
$4.69M 4.52% 77,208 – –
PFE icon
8
Pfizer
PFE
$141B
$2.96M 2.85% 100,000 -50,000 -33% -$1.48M
BIS icon
9
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.47M
$2.41M 2.32% 200,000 – –
LGND icon
10
Ligand Pharmaceuticals
LGND
$3.15B
$2.35M 2.27% +50,000 New +$2.35M
CLVS
11
DELISTED
Clovis Oncology, Inc.
CLVS
$1.13M 1.09% +25,000 New +$1.13M
SRNE
12
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$1.09M 1.05% 240,968 +36,000 +18% +$163K
RIGL icon
13
Rigel Pharmaceuticals
RIGL
$697M
$776K 0.75% 400,000 +300,000 +300% +$582K
AORT icon
14
Artivion
AORT
$2.07B
$740K 0.71% +75,000 New +$740K
CEMP
15
DELISTED
Cempra, Inc.
CEMP
$548K 0.53% 50,000 – –
ARIA
16
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$540K 0.52% 100,000 +25,000 +33% +$135K
KIN
17
DELISTED
Kindred Biosciences, Inc.
KIN
$463K 0.45% 50,000 – –
FCSC
18
DELISTED
Fibrocell Science Inc.
FCSC
$458K 0.44% 157,769 – –
SCMP
19
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$336K 0.32% 51,630 -45,000 -47% -$293K
IMNN icon
20
Imunon
IMNN
$15M
$296K 0.29% 100,000 – –
STML
21
DELISTED
Stemline Therapeutics, Inc.
STML
$205K 0.2% 16,464 – –
VIRX
22
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$179K 0.17% +25,000 New +$179K
ZGNX
23
DELISTED
Zogenix, Inc.
ZGNX
$173K 0.17% 150,000 -100,000 -40% -$115K
BMY icon
24
Bristol-Myers Squibb
BMY
$96B
– – 0 – –
CYTK icon
25
Cytokinetics
CYTK
$4.23B
– – -41,666 Closed -$199K
1
2